BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 228.00
+0.20 (0.09%)
Aug 21, 2026, 4:08 PM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 329.19 billion as of August 21, 2026. Its market cap has increased by 23.81% in one year.
Market Cap
329.19B
Enterprise Value
305.28B
Revenue
48.06B
Ranking
n/a
PE Ratio
64.02
Stock Price
228.00
ChartMarket Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 329.19B, an increase of 4,815.68%. That is a compound annual growth rate of 44.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 329.19B | 25.80% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 199.36B |
| Innovent Biologics | 168.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 129.67B |
| Sino Biopharmaceutical | 85.38B |
| Akeso | 83.82B |
| RemeGen | 71.41B |
| Biocytogen Pharmaceuticals (Beijing) | 62.15B |
| Genscript Biotech | 61.80B |